Across TCGA pan-cancer cohorts, CD247 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated CD247 data layer compared with 25 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher CD247 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated CD247 expression acts as an unfavorable survival marker, although some lineages such as PDAC and HNSC show a favorable association.

PDAC, LUAD, and HNSC are the cancer types where CD247 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	DFS	Median	III,IV	0.988	0.319	.006	6	view →
LUAD	OS	Median	II,III,IV	0.858	0.999	.027	3	view →
HNSC	DFS	Median	IV	0.795	0.553	.034	1	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: CD247 tumor-vs-normal RNA expression · all CD247 data types